2C8Z, 2C84, 2C83, 2C82, 2C81, 2C80,

Malignant Neoplasms Of Male Genital Organs – ICD 11 Codes

Definition of Malignant Neoplasms Of Male Genital Organs: A primary or metastatic malignant neoplasm involving the male reproductive system. Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, and testicular embryonal carcinoma.

Coding Note:

  • Includes malignant neoplasm of skin of male genital organs

Exclusions:

  • Malignant mesenchymal neoplasms

Malignant neoplasms of testis

Definition of Malignant neoplasms of testis: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukaemia, and lymphoma.

ICD 11 Code For Malignant neoplasms of testis

  2C80  Malignant neoplasms of testis

Exclusions:

  • Malignant mesenchymal neoplasms

2C80.2 Germ cell tumour of testis

Definition of Germ cell tumour of testis: A germ cell tumour arising from the testis. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumour.

2C80.Y Other specified malignant neoplasms of testis

2C80.Z Malignant neoplasms of testis unspecified

Malignant neoplasms of penis

Definition of Malignant neoplasms of penis: A primary or metastatic malignant neoplasm that affects the penis. Representative examples include penile carcinoma and penile sarcoma.

ICD 11 Code For Malignant neoplasms of penis

  2C81  Malignant neoplasms of penis

Exclusions:

  • Malignant mesenchymal neoplasms

Coded Elsewhere:

  • Verrucous squamous cell carcinoma of penis (2C31.0)

2C81.0 Squamous cell carcinoma of penis

Definition of Squamous cell carcinoma of penis: A squamous cell carcinoma arising from the penis. It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin. Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision. Human papilloma virus is present in a subset of penile squamous cell carcinomas. Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumour with inguinal nodal and skin metastases. Morphologic variants include the basaloid carcinoma, warty (condylomatous) carcinoma, verrucous carcinoma, and sarcomatoid (spindle cell) carcinoma.

Coded Elsewhere:

  • Verrucous squamous cell carcinoma of penis (2C31.0)

2C81.1 Melanoma of penis

Inclusions:

  • Melanoma of skin of penis
  • Melanoma of mucocutaneous epithelium of penis

2C81.Y Other specified malignant neoplasm of penis

2C81.Z Malignant neoplasms of penis unspecified

Malignant neoplasms of prostate

Definition of Malignant neoplasms of prostate: Prostate cancer contributes significantly to the overall cancer burden, being the most frequent malignant neoplasia in men. The number of cases has continuously increased over the past decades, partly due to the higher life expectancy. An additional factor is the Western lifestyle, characterised by a highly caloric diet and lack of physical exercise. Epidemiological data indicates that black people are most susceptible, followed by white people, while Asian people have the lowest risk. The extent to which prostate cancer mortality can be reduced by PSA screening, is currently being evaluated. Histopathological diagnosis and grading play a major role in the management of prostate cancer

ICD 11 Code For Malignant neoplasms of prostate

  2C82  Malignant neoplasms of prostate

Exclusions:

  • Malignant mesenchymal neoplasms

2C82.0 Adenocarcinoma of prostate

Definition of Adenocarcinoma of prostate: An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumours afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.

2C82.Y Other specified malignant neoplasms of prostate

2C82.Z Malignant neoplasms of prostate unspecified

Malignant neoplasms of scrotum

ICD 11 Code For Malignant neoplasms of scrotum

  2C83  Malignant neoplasms of scrotum

Inclusions:

  • malignant neoplasm of skin of scrotum

Exclusions:

  • Malignant mesenchymal neoplasms

2C83.0 Squamous cell carcinoma of scrotum

2C83.Y Other specified malignant neoplasms of scrotum

2C83.Z Malignant neoplasms of scrotum unspecified

Malignant neoplasms of other specified male genital organs

ICD 11 Code For Malignant neoplasms of other specified male genital organs

  2C84  Malignant neoplasms of other specified male genital organs

Exclusions:

  • Malignant mesenchymal neoplasms

Malignant neoplasms of male genital organs unspecified

ICD 11 Code For Malignant neoplasms of male genital organs unspecified

  2C8Z  Malignant neoplasms of male genital organs unspecified

Coding Note:

  • Includes malignant neoplasm of skin of male genital organs

Similar Posts

Leave a Reply

Your email address will not be published.